本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

乌龙制药

13.58
+0.62004.78%
盘后13.45-0.1300-0.96%16:59 EDT
成交量:73.74万
成交额:978.45万
市值:6.26亿
市盈率:-4.46
高:13.62
开:12.92
低:12.89
收:12.96
数据加载中...
2024/03/04

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/18

重要事件披露

Form 8-K - Current report
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/28

SEC问询函

Form CORRESP - Correspondence
2023/11/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/16

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/13

SEC问询函

Form CORRESP - Correspondence